← Back to Skills Marketplace
aipoch-ai

Biotech Pitch Deck Narrative

by AIpoch · GitHub ↗ · v0.1.0 · MIT-0
cross-platform ⚠ suspicious
231
Downloads
0
Stars
0
Active Installs
1
Versions
Install in OpenClaw
/install biotech-pitch-deck-narrative
Description
Use when creating biotech pitch decks, translating scientific data for investors, preparing fundraising presentations, or developing investor Q&A. Transforms...
README (SKILL.md)

Biotech Pitch Deck Narrative

Overview

Strategic communication tool that translates complex biotechnology innovations into compelling business narratives optimized for venture capital, pharmaceutical partnerships, and public market investors.

Key Capabilities:

  • Science Translation: Convert technical data into business value language
  • Narrative Architecture: Structure Problem→Solution→Market→Traction→Vision flow
  • Stage Optimization: Tailor messaging for seed through IPO fundraising
  • Investor Calibration: Adapt for generalist vs. specialist audiences
  • Risk Mitigation: Frame scientific and regulatory risks as manageable challenges
  • Q&A Preparation: Anticipate investor questions and prepare responses

When to Use

✅ Use this skill when:

  • Preparing Series A/B pitch decks for VC presentations
  • Creating management presentations for IPO roadshows
  • Developing BD materials for pharma partnership discussions
  • Crafting executive summaries for grant applications
  • Rehearsing investor Q&A for earnings calls
  • Translating clinical data into commercial narratives
  • Adapting academic presentations for business audiences

❌ Do NOT use when:

  • Scientific conference presentations → Use technical language
  • Regulatory submission documents → Use formal FDA/EMA formats
  • Internal R&D team communications → Use full scientific detail
  • Patent applications → Use precise legal/scientific terminology
  • Patient-facing materials → Use lay-summary-gen

Integration:

  • Upstream: market-access-value (commercial assessment), competitor-trial-monitor (competitive landscape)
  • Downstream: business-model-canvas (strategy development), investor-relations-prep (ongoing communications)

Core Capabilities

1. Science-to-Business Translation

Convert technical concepts into investor-friendly language:

from scripts.narrative_engine import BiotechNarrativeEngine

engine = BiotechNarrativeEngine()

# Translate technical description
translation = engine.translate_science(
    technical_description="""
    Our proprietary AAV9-based gene therapy utilizes a codon-optimized 
    transgene under control of a liver-specific promoter to restore 
    functional enzyme in patients with MPS I deficiency.
    """,
    audience="generalist_vc",
    preserve_accuracy=True
)

print(translation.business_narrative)
# "One-time gene therapy delivering a functional copy of the missing enzyme, 
#  potentially curing MPS I rather than managing symptoms"

Translation Strategies:

Technical Concept Business Translation Why It Works
"CRISPR-Cas9 gene editing" "Precision genetic medicine platform" Platform implies scalability
"Phase II clinical data" "De-risked asset with human proof-of-concept" Reduces perceived risk
"Off-target effects" "Industry-leading specificity profile" Competitive framing
"MOA via JAK-STAT pathway" "Novel mechanism addressing root cause" Value proposition

2. Narrative Architecture

Structure pitch deck flow for maximum impact:

# Generate complete narrative arc
narrative = engine.build_narrative(
    company_stage="series_b",
    science_type="gene_therapy",
    clinical_stage="phase_2",
    target_market="rare_disease",
    key_differentiation="one_time_cure"
)

# Access each component
print(narrative.hook)           # Opening grab
print(narrative.problem)        # Market pain point
print(narrative.solution)       # Your approach
print(narrative.traction)       # Validation to date
print(narrative.ask)            # Funding request

Narrative Structure:

  1. Hook (30 seconds): Why this, why now, why you
  2. Problem ($B+ market): Unmet medical need, current standard limitations
  3. Solution: Your technology/platform, mechanism of action
  4. Traction: Clinical data, partnerships, validation
  5. Market: Size, competition, your advantage
  6. Team: Track record, why you'll succeed
  7. Ask: Funding amount, use of proceeds, milestones

3. Stage-Specific Optimization

Calibrate message depth for funding round:

# Optimize for different stages
seed_narrative = engine.optimize_for_stage(
    base_narrative=narrative,
    stage="seed",
    focus="team_and_vision"  # Seed cares about team and big idea
)

series_a_narrative = engine.optimize_for_stage(
    base_narrative=narrative,
    stage="series_a",
    focus="proof_of_concept"  # Series A needs validation
)

ipo_narrative = engine.optimize_for_stage(
    base_narrative=narrative,
    stage="ipo",
    focus="commercial_readiness"  # IPO requires near-term revenue
)

Stage Requirements:

Stage Key Questions Focus Areas
Seed ($500K-$2M) Can you execute? Team, vision, early validation
Series A ($10-30M) Does it work? POC data, IP position, market entry
Series B ($30-75M) Will it scale? Phase 2/3 data, BD traction, team expansion
Series C/IPO ($100M+) Commercial execution Registration trials, launch prep, revenue path

4. Investor Audience Calibration

Adapt tone and depth for different investor types:

# Calibrate for specific investor
calibrated = engine.calibrate_for_audience(
    narrative=narrative,
    investor_type="healthcare_vc",  # vs "generalist_vc" or "pharma_corp"
    technical_depth="moderate",      # Depth of scientific detail
    risk_tolerance="high"            # Early vs late stage framing
)

Investor Types:

  • Generalist VC: Focus on market size, business model, team pedigree
  • Healthcare VC: Balance science rigor with commercial potential
  • Pharma BD: Emphasize strategic fit, validation data, partnership potential
  • Public Market: Highlight near-term catalysts, revenue projections, risk mitigation

Common Patterns

Pattern 1: Clinical-Stage Therapeutics

Scenario: Phase 2 biotech raising Series B.

# Generate complete pitch narrative
python scripts/main.py \
  --science "Small molecule inhibitor targeting mutant KRAS G12C" \
  --stage "phase_2" \
  --indication "lung_cancer" \
  --data "ORR 45%, median PFS 6.5 months" \
  --competition "Mirati, J&J" \
  --output series_b_narrative.json

Narrative Elements:

  • Problem: KRAS mutations in 30% of cancers; previously "undruggable"
  • Solution: First-in-class covalent inhibitor with superior selectivity
  • Traction: Phase 2 data showing 45% response rate, durable responses
  • Market: $15B+ opportunity across multiple tumor types
  • Differentiation: Best-in-class potency, favorable safety profile
  • Ask: $75M to complete Phase 3 and prepare NDA

Pattern 2: Platform Company

Scenario: Novel delivery platform company raising seed.

platform_narrative = engine.generate_platform_narrative(
    platform_technology="Lipid nanoparticle for CNS delivery",
    differentiator="Crosses BBB with 50x improvement over existing LNPs",
    applications=["Alzheimer's", "Parkinson's", "brain_cancer"],
    stage="seed",
    target="platform_value_creation"
)

Platform Story Arc:

  • Platform Thesis: Solving delivery problem unlocks multiple indications
  • Validation: Proof-of-mechanism in 2+ disease models
  • Breadth: Pipeline across CNS, oncology, rare disease
  • **Partnership Appeal": Pharma interest in accessing CNS targets
  • Scalability: Manufacturing platform supports multiple assets

Pattern 3: MedTech Device

Scenario: Surgical robotics company Series A.

device_narrative = engine.generate_device_narrative(
    device_type="surgical_robot",
    clinical_benefit="50% reduction in complications, 30% faster recovery",
    regulatory_path="510k_de_novo",
    reimbursement="CPT_code_established",
    stage="series_a"
)

Device-Specific Elements:

  • Clinical Evidence: Superior outcomes vs. standard of care
  • Economic Value: Cost savings to healthcare system
  • Regulatory Clarity: Clear FDA pathway, reimbursement strategy
  • Adoption Strategy: Training, support, key opinion leader engagement

Pattern 4: Pharma Partnership Pitch

Scenario: Out-licensing asset to big pharma.

# Generate BD materials
python scripts/main.py \
  --mode partnership \
  --asset "Phase 2 ready asset" \
  --indication "NASH" \
  --data_package "Phase 1b complete, biomarker validated" \
  --partner_profile "novo_nordisk" \
  --output bd_presentation.json

Partnership Framing:

  • Strategic Fit: Complements partner's metabolism franchise
  • Validation: De-risked with human proof-of-mechanism
  • Value Creation: $500M+ peak sales potential
  • Deal Structure: Flexible partnership terms proposed

Complete Workflow Example

Building comprehensive fundraising materials:

from scripts.narrative_engine import BiotechNarrativeEngine
from scripts.slide_generator import SlideGenerator
from scripts.qa_prep import QAPreparation

# Initialize
engine = BiotechNarrativeEngine()
slides = SlideGenerator()
qa = QAPreparation()

# Step 1: Generate core narrative
narrative = engine.build_narrative(
    company_stage="series_a",
    therapeutic_area="oncology",
    modality="cell_therapy",
    clinical_stage="phase_1",
    key_differentiation="allogeneic_off_the_shelf"
)

# Step 2: Create slide-by-slide guidance
slide_guide = slides.generate_guide(
    narrative=narrative,
    n_slides=12,
    include_visual_suggestions=True
)

# Step 3: Prepare Q&A
qa_prep = qa.generate_qa(
    narrative=narrative,
    investor_type="healthcare_vc",
    depth="comprehensive"
)

# Step 4: Export complete package
engine.export_package(
    narrative=narrative,
    slides=slide_guide,
    qa=qa_prep,
    output_dir="series_a_pitch_package/"
)

Quality Checklist

Narrative Quality:

  • Opening hook grabs attention in 30 seconds
  • Problem is a $B+ market with clear unmet need
  • Solution is differentiated vs. competition
  • Traction validates technical and commercial hypotheses
  • Team has relevant track record
  • Ask is specific with clear milestones

Translation Accuracy:

  • Scientific claims remain accurate after simplification
  • No misleading statements or exaggerated claims
  • Risk factors disclosed appropriately
  • Regulatory pathway is realistic
  • Market size assumptions are defensible

Investor Alignment:

  • Appropriate for stage and investor type
  • Addresses likely investor concerns proactively
  • Financial projections are reasonable
  • Exit strategy is credible

Before Presentation:

  • CRITICAL: Legal review of all claims
  • CRITICAL: Scientific accuracy check by domain expert
  • Rehearsed with feedback from experienced biotech investors
  • Backup slides prepared for detailed questions

Common Pitfalls

Translation Errors:

  • Oversimplification → "Our drug cures cancer" (misleading)

    • ✅ "Our drug showed tumor shrinkage in 40% of patients"
  • Jargon overload → Technical terms without explanation

    • ✅ Use analogies: "Like a molecular GPS guiding drugs to tumors"
  • Hiding risks → No mention of side effects or competition

    • ✅ Acknowledge risks with mitigation strategies

Narrative Mistakes:

  • Technology in search of problem → Cool science, no market

    • ✅ Start with problem, solution follows naturally
  • Ignoring competition → "We have no competitors"

    • ✅ Acknowledge competition, explain differentiation
  • Unrealistic projections → $10B revenue in Year 3

    • ✅ Conservative estimates with clear assumptions

Stage Mismatch:

  • Seed deck with Phase 3 projections → Too far ahead

    • ✅ Match milestones to stage-appropriate timelines
  • IPO presentation to seed investors → Wrong focus

    • ✅ Tailor depth and emphasis to investor sophistication

References

Available in references/ directory:

  • vc_presentation_best_practices.md - Venture capital pitch guidelines
  • biotech_valuation_models.md - Valuation methodologies by stage
  • regulatory_pathway_guides.md - FDA/EMA approval timelines
  • market_sizing_methodologies.md - TAM/SAM/SOM calculations
  • investor_question_bank.md - Common Q&A by investor type
  • competitive_landscape_templates.md - Positioning frameworks

Scripts

Located in scripts/ directory:

  • main.py - CLI interface for narrative generation
  • narrative_engine.py - Core story architecture
  • science_translator.py - Technical to business translation
  • slide_generator.py - Deck structure and visual guidance
  • qa_preparation.py - Investor Q&A preparation
  • competitive_analyzer.py - Market positioning analysis
  • risk_framer.py - Risk mitigation messaging
  • stage_optimizer.py - Funding round calibration

Limitations

  • Not Financial Advice: Cannot provide investment recommendations
  • Regulatory Compliance: Does not ensure SEC or other regulatory compliance
  • Market Specificity: May not capture niche investor preferences
  • Real-Time Adaptation: Cannot adjust to live investor reactions
  • Confidentiality: Does not handle material non-public information protection
  • Legal Review: All materials require legal counsel review before use

Parameters

Parameter Type Default Required Description
--science string - Yes* Scientific description of technology
--stage string - Yes* Funding stage (pre-seed, seed, series-a, etc.)
--audience string - Yes* Target audience type (generalist-vc, healthcare-vc, etc.)
--section string - No Section to rewrite (hook, problem, solution, etc.)
--content string - No Content to rewrite
--input string - No Input file path
--output, -o string - No Output file path

*Required depending on subcommand

Usage

Basic Usage

# Generate narrative from science description
python scripts/main.py generate --science "CRISPR gene therapy for sickle cell" --stage series-a --audience healthcare-vc

# Rewrite specific section
python scripts/main.py rewrite --section technology --content "We use AAV vectors..." --audience generalist-vc

# Analyze existing pitch deck
python scripts/main.py analyze --input pitch.pptx --stage series-a

Risk Assessment

Risk Indicator Assessment Level
Code Execution Python script executed locally Low
Network Access No external API calls Low
File System Access Read/write files Low
Data Exposure May process confidential business info Medium
Regulatory Does not ensure SEC compliance Medium

Security Checklist

  • No hardcoded credentials or API keys
  • No unauthorized file system access
  • Output does not expose sensitive information
  • Prompt injection protections in place
  • Error messages sanitized
  • Script execution in sandboxed environment

Prerequisites

# Python 3.7+
# No additional packages required (uses standard library)

Evaluation Criteria

Success Metrics

  • Successfully generates pitch narratives
  • Adapts content to different investor types
  • Rewrites technical content for business audiences
  • Provides stage-appropriate messaging

Test Cases

  1. Generate Narrative: Science description → Complete pitch narrative
  2. Rewrite Section: Technical content → Business-friendly version
  3. Audience Adaptation: Same content for different VC types

Lifecycle Status

  • Current Stage: Draft
  • Next Review Date: 2026-03-06
  • Known Issues: Help text in Chinese
  • Planned Improvements:
    • Translate all interface text to English
    • Add more investor personas
    • Enhance narrative templates

💼 Business Note: Successful biotech fundraising requires balancing scientific credibility with business appeal. This tool helps structure narratives, but the underlying science and team execution ultimately determine success. Always maintain integrity—overpromising destroys credibility with sophisticated investors.

Usage Guidance
Proceed cautiously. The skill appears to do what it claims (generate pitch narratives), but there are inconsistencies and a couple of practical risks: (1) SKILL.md examples reference a different module/class than the included scripts/main.py — verify which implementation will actually run; (2) the allowed-tools list includes Read/Write/Bash/Edit, which would let the agent access local files/shell even though no env credentials are requested. Before installing, (a) verify the code you will run (open and review scripts/main.py and any other code paths), (b) run the skill in an isolated sandbox with non-sensitive sample data to confirm behavior, (c) restrict or remove broad tool permissions if your environment allows it, and (d) avoid feeding real patient-level or regulatory documents until you've confirmed the skill's handling of sensitive content. If provenance matters, request the publisher/source (currently unknown) or choose a skill with clear source and review history.
Capability Analysis
Type: OpenClaw Skill Name: biotech-pitch-deck-narrative Version: 0.1.0 The skill bundle is a framework for generating biotech pitch deck narratives and translating scientific data for investors. While the documentation in SKILL.md describes a complex system with multiple scripts (e.g., narrative_engine.py, science_translator.py) that are missing from the bundle, the provided main.py is a harmless, non-functional skeleton. There is no evidence of malicious intent, data exfiltration, or dangerous execution patterns; the requested tool permissions (Bash, Edit) are consistent with the stated purpose of content generation and file management.
Capability Assessment
Purpose & Capability
The described capability (translating scientific data into investor narratives) aligns with the included Python code which generates narrative components. However, SKILL.md's example code imports a non-existent module/class (scripts.narrative_engine / BiotechNarrativeEngine) while the repo contains scripts/main.py defining PitchDeckNarrative. This mismatch suggests the docs and code are out of sync.
Instruction Scope
SKILL.md is mostly focused on narrative generation and usage examples. It declares allowed-tools: "Read Write Bash Edit", which grants file and shell access; yet the skill declares no required env vars or config paths. Examples show calling a CLI on pitch.pptx, but the shipped main.py does not implement parsing of such files. The combination of broad allowed-tools and mismatch between examples and code means the agent could be given permission to read/write files even though the SKILL.md examples don't reliably show how that data is used.
Install Mechanism
No install spec; the skill is instruction-plus-source only. That is lower risk than arbitrary downloads. requirements.txt only lists small standard packages (dataclasses, enum). There is no installer that fetches remote code.
Credentials
The skill requests no environment variables, credentials, or config paths. That is proportionate for a narrative-generation utility. There are no declared secrets or unrelated credential requests.
Persistence & Privilege
always:false (no forced permanent inclusion) and normal autonomous invocation settings. Nothing requests elevated platform privileges or modifications to other skills' configuration.
How to Use
  1. Make sure OpenClaw is installed (local or Docker)
  2. Run the install command in chat: /install biotech-pitch-deck-narrative
  3. After installation, invoke the skill by name or use /biotech-pitch-deck-narrative
  4. Provide required inputs per the skill's parameter spec and get structured output
Version History
v0.1.0
Initial release — a strategic toolkit for transforming biotech science into persuasive investor narratives. - Translates technical scientific and clinical data into business-focused storytelling for investors. - Provides modular narrative structures (Problem→Solution→Market→Traction→Vision) tailored for fundraising decks, partnerships, and public market communications. - Optimizes message depth for all funding stages (seed to IPO) and calibrates for different investor types (VC, pharma, public markets). - Includes Q&A preparation and framing of scientific/regulatory risk for investor audiences. - Integrates upstream/downstream with other commercialization and business development tools.
Metadata
Slug biotech-pitch-deck-narrative
Version 0.1.0
License MIT-0
All-time Installs 0
Active Installs 0
Total Versions 1
Frequently Asked Questions

What is Biotech Pitch Deck Narrative?

Use when creating biotech pitch decks, translating scientific data for investors, preparing fundraising presentations, or developing investor Q&A. Transforms... It is an AI Agent Skill for Claude Code / OpenClaw, with 231 downloads so far.

How do I install Biotech Pitch Deck Narrative?

Run "/install biotech-pitch-deck-narrative" in the OpenClaw or Claude Code chat to install it in one step — no extra setup required.

Is Biotech Pitch Deck Narrative free?

Yes, Biotech Pitch Deck Narrative is completely free, licensed under MIT-0. You can download, install and use it at no cost.

Which platforms does Biotech Pitch Deck Narrative support?

Biotech Pitch Deck Narrative is cross-platform and runs anywhere OpenClaw / Claude Code is available (cross-platform).

Who created Biotech Pitch Deck Narrative?

It is built and maintained by AIpoch (@aipoch-ai); the current version is v0.1.0.

💬 Comments